BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1060179)

  • 1. Editorial: Transfer factor therapy: current status.
    Levin AS
    South Med J; 1975 Dec; 68(12):1465-7. PubMed ID: 1060179
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of immunologic deficiency conditions by means of transfer factor].
    Kobielowa Z
    Pediatr Pol; 1975 Nov; 50(11):1393-7. PubMed ID: 1103073
    [No Abstract]   [Full Text] [Related]  

  • 3. [Transfer factor. Immunologic basis and therapeutic experience].
    Hitzig WH; Fontanellaz HP; Müntener U; Paul S; Spitler LE; Fudenberg HH
    Schweiz Med Wochenschr; 1972 Sep; 102(35):1237-44. PubMed ID: 5054632
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of therapy with dialyzable leukocyte extracts containing transfer factor activity on antibody-dependent cytotoxic activity in humans.
    Nékám K; Láng I; Török K; Kalmár L; Gergely P; Petrányi G
    Clin Immunol Immunopathol; 1979 Aug; 13(4):407-12. PubMed ID: 226302
    [No Abstract]   [Full Text] [Related]  

  • 5. Wiskott-Aldrich syndrome with 18-year survival. Treatment with transfer factor.
    Sellars WA; South MA
    Am J Dis Child; 1975 May; 129(5):622-7. PubMed ID: 806224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfer factor--clinical enigma. Clinical uses of transfer factor (second of two parts).
    Graziano FM; Dwyer JM
    Conn Med; 1978 Jan; 42(1):1-4. PubMed ID: 620531
    [No Abstract]   [Full Text] [Related]  

  • 7. Transfer factor in immunodeficiency diseases.
    Spitler LE
    Ann N Y Acad Sci; 1979; 332():228-35. PubMed ID: 119460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transfer factor. Properties and possible therapeutic applications (author's transl)].
    Grob PJ; Reymond JF; Häcki MA; Frey-Wettstein M
    MMW Munch Med Wochenschr; 1975 Mar; 117(13):517-24. PubMed ID: 805916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfer factor therapy in immunodeficiency.
    Griscelli C
    Birth Defects Orig Artic Ser; 1975; 11(1):462-4. PubMed ID: 1148388
    [No Abstract]   [Full Text] [Related]  

  • 10. [Transfer factor treatment of chronic mucocutaneous candidiasis].
    Karmazsin L; Oláh E; Szegedi G
    Acta Paediatr Acad Sci Hung; 1976; 17(3):183-91. PubMed ID: 1027316
    [No Abstract]   [Full Text] [Related]  

  • 11. [Personal experiences of immunotherapy using the transfer factor].
    D'Amelio R; Franchi F; Aiuti F
    Minerva Med; 1976 May; 67(24):1613-6. PubMed ID: 934516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preliminary experience with the treatment of a case of Wiskott-Aldrich syndrome with transfer factor].
    Balsamo V; Brai M; Mogavero S; Tolone G; La Grutta A
    Minerva Pediatr; 1977 Mar; 29(10):651-5. PubMed ID: 875932
    [No Abstract]   [Full Text] [Related]  

  • 13. Transfer factor II: results of therapy.
    Spitler LE; Levin AS; Fudenberg HH
    Birth Defects Orig Artic Ser; 1975; 11(1):449-56. PubMed ID: 1096990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new approach to immunotherapy: the transfer factor].
    Di Padova F
    Minerva Med; 1979 May; 70(25):1773-85. PubMed ID: 379697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transfer factor and thymosin in the treatment of Wiskott-Aldrich syndrome].
    Franchi F; Segni G; Stabile A; Ammirati P; Aiuti F
    Minerva Pediatr; 1978 Apr; 30(8):609-13. PubMed ID: 661768
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic prospects in some immune deficiency syndromes and other pathological conditions connected with immune disorders].
    Kraj M; Cieśluk S
    Acta Haematol Pol; 1976 OCT-DEC; 7(4):327-35. PubMed ID: 793282
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy using the transfer factor in combined immunologic deficiency syndromes].
    Dienst C; Waldschmidt R; Mueller-Eckhardt C
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1810-2. PubMed ID: 1030113
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial: Transfer-factor therapy of immunodeficiencies.
    Polmar SH
    N Engl J Med; 1973 Dec; 289(26):1420-1. PubMed ID: 4127762
    [No Abstract]   [Full Text] [Related]  

  • 19. [Primary defective immunopathies].
    Salfner B
    Internist (Berl); 1977 May; 18(5):248-54. PubMed ID: 326715
    [No Abstract]   [Full Text] [Related]  

  • 20. Transfer factor: a potential agent for immunotherapy of cancer.
    Meier CR; LoBuglio AF
    World J Surg; 1977 Sep; 1(5):617-23. PubMed ID: 272085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.